Email

(S)-3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,6-dimethoxybenzamide

An antipsychotic agent that is specific for Dopamine D2 Receptors. It has been shown to be effective in the treatment of Schizophrenia.